Sprycel (dasatinib tablets - Bristol-Myers Squibb; generic) — Cigna

Initial criteria

• Approve for 1 year if ALL of the following (A, B, C, and D) are met:
• A) Patient age ≥ 18 years; AND
• B) Patient has metastatic or unresectable disease; AND
• C) Patient has an activating KIT mutation; AND
• D) Patient has tried at least one systemic regimen.

Approval duration

1 year